References
- Lagakos SW, Gable AR eds., Methodological Challenges in Biomedical HIV Prevention Trials. Washington DC: National Academies Press; 2008:37–68.
- Kline EE, Treat EG, Averna TA, Davis MS, Smith AY, Sillerud LO. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection. J. Urol. 2006;176(5):2274–2279.
- Smith TJ. Applications of chitosan and alginate in biotechnology. Curr. Top. Biotechnol. 2004;1:129–132.
- Schols D, Baba M, Pauwels R, Desmyter J, De Clercq E. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. PNAS. 1989;86:3322–3326.
- Cushman M, Wang PL, Chang SH, Wild C, De Clercq E, Schols D, Goldman ME, Bowen JA. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight. J. Med. Chem. 1991;34(1):329–337.